Intestinal Cell News 2.19 May 27, 2016 | |
| |
TOP STORYAcquired Tissue-Specific Promoter Bivalency Is a Basis for PRC2 Necessity in Adult Cells Researchers found that epigenomes in adult mouse intestine and other self-renewing tissues show fewer and distinct bivalent promoters compared to embryonic stem cells. In adult animals, Polycomb Repressive Complex 2 (PRC2) specifically represses genes with acquired, tissue-restricted promoter bivalency. [Cell] Abstract | Graphical Abstract | |
| |
PUBLICATIONS(Ranked by impact factor of the journal)INTESTINAL CANCERS & DISEASESTRIM31 Promotes Atg5/Atg7-Independent Autophagy in Intestinal Cells Researchers report that human TRIM31 (tripartite motif), an intestine-specific protein localized in mitochondria, is essential for promoting lipopolysaccharide-induced Atg5/Atg7-independent autophagy. [Nat Commun] Full Article Growth Hormone Is Permissive for Neoplastic Colon Growth Investigators demonstrated that growth hormone (GH) suppresses p53 and reduces apoptosis in human colon cell lines as well as in induced human pluripotent stem cell-derived intestinal organoids, and confirmed in vivo that GH suppresses colon mucosal p53/p21. [Proc Natl Acad Sci USA] Abstract Investigators generated RhoGTPase-activating protein 17 (Arhgap17)-deficient mice and examined the effect in the epithelial and mucosal barriers of the intestine. [Sci Rep] Full Article To identify cancer-related long noncoding RNAs, the authors screened for those that are epigenetically silenced in colorectal cancer. [Sci Rep] Full Article Using a mouse model in which Krüppel-like factor 4 is deleted from quiescent BMI1+ intestinal stem cells, scientists observed increased proliferation from the BMI1+ lineage during homeostasis. [Stem Cell Reports] Full Article Knockdown of Linc-UFC1 Suppresses Proliferation and Induces Apoptosis of Colorectal Cancer Long intergenic noncoding RNA UFC1 (linc-UFC1) was overexpressed in colorectal cancer patient tissues and positively correlated with tumor grade, N stage and M stage. Inhibition of linc-UFC1 resulted in cell proliferation inhibition and G1 cell cycle arrest, which was mediated by cyclin D1, CDK4, Rb and phosphorylated Rb. [Cell Death Dis] Full Article Researchers found that acute T cell activation with anti-CD3 mAb induced stronger small intestinal mucosal damage in NOD2-/- mice compared with wild-type mice. [J Immunol] Abstract Scientists found that cullin 3 down-regulation could rescue folate deprivation-induced methionine adenosyltransferase IIα exhaustion and growth arrest in colorectal cancer cells. [FEBS J] Abstract INTESTINAL STEM CELL & ORGANOID RESEARCHThe authors identified a novel feedback mechanism in controlling intestinal regeneration and tumorigenesis in Drosophila. [eLife] Abstract | Download Full Article | |
| |
REVIEWSVagal Neurocircuitry and Its Influence on Gastric Motility The authors summarize the organization and function of vagovagal reflex control of the upper gastrointestinal tract, present data on the plasticity within these neurocircuits after stress, and discuss the gastrointestinal dysfunctions observed in Parkinson’s disease as examples of physiological adjustment and maladaptation of these reflexes. [Nat Rev Gastroenterol Hepatol] Abstract Visit our reviews page to see a complete list of reviews in the intestinal cell research field.
| |
INDUSTRY NEWSOncolytics Biotech Inc. announced preliminary data from a randomized Phase II clinical trial of its lead product, REOLYSIN®, in combination with FOLFOX-6 and bevacizumab in patients with advanced or metastatic colorectal cancer. [Oncolytics Biotech Inc.] Press Release Merrimack Pharmaceuticals, Inc. and Baxalta Incorporated jointly announced the initiation of a Phase I clinical study of Merrimack’s oligoclonal epidermal growth factor receptor inhibitor, MM-151, in combination with ONIVYDE® plus fluorouracil and leucovorin in patients with RAS wild-type metastatic colorectal cancer. [Merrimack Pharmaceuticals, Inc.] Press Release | |
From our sponsor: Learn about mucociliary differentiation of primary bronchial epithelial cells. Watch the video.
| |
EVENTSNEW ISSCR 2016 Annual Meeting Visit our events page to see a complete list of events in the intestinal cell community.
| |
JOB OPPORTUNITIESNEW Scientist – Intestinal Cell Biology (STEMCELL Technologies Inc.) Scientific Communications and Publishing Coordinator (STEMCELL Technologies Inc.) Technical Sales Representative (STEMCELL Technologies Inc.) Postdoctoral Position – Human Systems Immunology, Gut Inflammation and IBD (University College Cork) Associate Director – Intestinal Microbiota (Institute for Basic Science/POSTECH) Junior Principle Investigator – Gut Immunology (Institute for Basic Science/POSTECH) Postdoctoral Fellow – Norovirus-Intestinal Microbiota Interactions (University of Florida) PhD Studentship – Gut Bacterial Metabolism (Katholieke Universiteit Leuven) Research Assistant – Autoimmune/Cell Biology (Immunocore Ltd) Faculty Positions – Clinical Immunology (Oklahoma Medical Research Foundation) Grant Writer (Gladstone Institutes) Recruit Top Talent: Reach potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.
| |
Have we missed an important article or publication in Intestinal Cell News? Click here to submit! Comments or suggestions? Submit your feedback here. | |
|
Home Intestinal Cell News Volume 2.19 | May 27 2016